CYP4 ω-oxidises 14(R)-HDHA to MaR-L2

Stable Identifier
R-HSA-9027044
Type
Reaction [transition]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Cytochrome P450 (CYP) enzymes are thought to ω-hydroxylate (position 22) 14(R)-hydroxy-docosahexaenoic acid (14(R)-HDHA) to 14(R),22-dihydroxy-docosahexaenoic acid, namely maresin-like mediator 2 (MaR-L2) (Hong et al. 2014). CYP inhibition was found to decrease the amount of MaR-L2 formed (Hong et al. 2014). The exact CYP responsible for MaR-L2 formation is unknown but is likely to be a member of the CYP4 family as those enzymes mediate the ω-hydroxylation of fatty acids and eicosanoids (Kikuta et al. 2002). Diabetes results in delayed- or non-healing of wounds and is associated with impaired macrophage function (Brem & Tomic-Canic 2007). Leukocytes and platelets play critical roles in wound healing by mechanisms as yet unknown. Maresin-like mediators MaR-L1 and Mar-L2 are produced by leukocytes and platelets and have been shown (in vitro) to restore reparative functions of diabetic macrophages in wounds (Hong et al. 2014).

Literature References
PubMed ID Title Journal Year
25200603 Maresin-like lipid mediators are produced by leukocytes and platelets and rescue reparative function of diabetes-impaired macrophages

Hong, S, Lu, Y, Tian, H, Alapure, BV, Wang, Q, Bunnell, BA, Laborde, JM

Chem. Biol. 2014
Participants
Participant Of
Catalyst Activity
Catalyst Activity
Title
monooxygenase activity of CYP4 [endoplasmic reticulum membrane]
Physical Entity
Activity
Authored
Reviewed
Created
Cite Us!